BioLife Solutions, Inc. (DELISTED) (BLFS:DL)
38.61
0.00 (0.00%)
USD |
NASDAQ |
Oct 15, 16:00
BioLife Solutions Enterprise Value : 1.821B for Oct. 15, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 15, 2026 | 1.821B |
| October 14, 2026 | 1.821B |
| October 13, 2026 | 1.821B |
| October 12, 2026 | 1.821B |
| October 09, 2026 | 1.821B |
| October 08, 2026 | 1.821B |
| October 07, 2026 | 1.821B |
| October 06, 2026 | 1.821B |
| October 05, 2026 | 1.821B |
| October 02, 2026 | 1.757B |
| October 01, 2026 | 1.731B |
| September 30, 2026 | 1.833B |
| September 29, 2026 | 1.851B |
| September 28, 2026 | 1.847B |
| September 25, 2026 | 1.815B |
| September 24, 2026 | 1.819B |
| September 23, 2026 | 1.778B |
| September 22, 2026 | 1.795B |
| September 21, 2026 | 1.751B |
| September 18, 2026 | 1.727B |
| September 17, 2026 | 1.735B |
| September 16, 2026 | 1.699B |
| September 15, 2026 | 1.712B |
| September 14, 2026 | 1.665B |
| September 11, 2026 | 1.642B |
| Date | Value |
|---|---|
| September 10, 2026 | 1.641B |
| September 09, 2026 | 1.641B |
| September 08, 2026 | 1.663B |
| September 04, 2026 | 1.657B |
| September 03, 2026 | 1.670B |
| September 02, 2026 | 1.689B |
| September 01, 2026 | 1.667B |
| August 31, 2026 | 1.746B |
| August 28, 2026 | 1.712B |
| August 27, 2026 | 1.752B |
| August 26, 2026 | 1.742B |
| August 25, 2026 | 1.753B |
| August 24, 2026 | 1.752B |
| August 21, 2026 | 1.747B |
| August 20, 2026 | 1.741B |
| August 19, 2026 | 1.716B |
| August 18, 2026 | 1.642B |
| August 17, 2026 | 1.666B |
| August 14, 2026 | 1.648B |
| August 13, 2026 | 1.656B |
| August 12, 2026 | 1.643B |
| August 11, 2026 | 1.636B |
| August 10, 2026 | 1.627B |
| August 07, 2026 | 1.628B |
| August 06, 2026 | 1.592B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Repligen Corp. | 9.779B |
| Agilent Technologies, Inc. | 50.96B |
| Danaher Corp. | 184.51B |
| Thermo Fisher Scientific, Inc. | 293.73B |
| West Pharmaceutical Services, Inc. | 26.92B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 45.10M |
| Revenue (Quarterly) | 28.47M |
| Total Expenses (Quarterly) | -16.64M |
| EPS Diluted (Quarterly) | 0.915 |
| Gross Profit Margin (Quarterly) | 63.69% |
| Earnings Yield | 2.50% |
| Operating Earnings Yield | 0.16% |
| Normalized Earnings Yield | 2.504 |